NCT06184633View on ClinicalTrials.gov

DUTCH Weight Control in Atrial Fibrillation Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

July 21, 2024

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2027

Conditions
Atrial FibrillationObesityWeight Loss
Interventions
DRUG

Semaglutide 3.2 MG/ML

Intervention arm receives semaglutide in addition to combined lifestyle intervention

DRUG

Placebo

Control arm receives placebo in addition to combined lifestyle intervention

Trial Locations (1)

Unknown

RECRUITING

Rijnstate Hospital, Arnhem

All Listed Sponsors
lead

Rijnstate Hospital

OTHER